1.Janakiram M, Abadi YM, Sparano JA, Zang X. (2012) T cell coinhibition and immunotherapy in human breast cancer.. Discov Med, 14 (77):(229-36). [PMID:23114578][10.1021/op500134e]
2.Greaves P, Gribben JG. (2013) The role of B7 family molecules in hematologic malignancy.. Blood, 121 (5):(734-44). [PMID:23223433][10.1021/op500134e]
3.Tang PA, Heng DY. (2013) Programmed death 1 pathway inhibition in metastatic renal cell cancer and prostate cancer.. Curr Oncol Rep, 15 (2):(98-104). [PMID:23263823][10.1021/op500134e]
4.Lu J, Lee-Gabel L, Nadeau MC, Ferencz TM, Soefje SA. (2015) Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy.. J Oncol Pharm Pract, 21 (6):(451-67). [PMID:24917416][10.1021/op500134e]
5.Johnson DB, Rioth MJ, Horn L. (2014) Immune checkpoint inhibitors in NSCLC.. Curr Treat Options Oncol, 15 (4):(658-69). [PMID:25096781][10.1021/op500134e]
6.Sasikumar PG, Ramachandra M. (2017) Small-molecule antagonists of the immune checkpoint pathways: concept to clinic.. Future Med Chem, 9 (12):(1305-1308). [PMID:28771036][10.1021/op500134e]
7.Miao X, Xu R, Fan B, Chen J, Li X, Mao W, Hua S, Li B. (2018) PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin.. Sci Rep, 8 (1):(1605). [PMID:29371688][10.1021/op500134e]
8.Guzik K, Zak KM, Grudnik P, Magiera K, Musielak B, Törner R, Skalniak L, Dömling A, Dubin G, Holak TA. (2017) Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1.. J Med Chem, 60 (13):(5857-5867). [PMID:28613862][10.1021/op500134e]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
